Choose a model
Each card values Arcellx a different way, shown at our starting inputs. Pick one to see and change how it works.
Set your assumptions
Arcellx on revenue: sales per share grow and the stock trades at a normal price-to-sales multiple. For companies not yet profitable.
Years to project
Growth of revenue per share
Revenue per share; starts at its own recent growth
Exit P/S
Starts at its industry's median P/S
Your desired return
Margin of safety
More
Your buy price
The expected return is measured from it; starts at today's price
How it's worked out
Today's revenue per share
Last twelve months
$0.38
Revenue in 2031
Grows 0.0% a year for 5 years
$0.38
Price in 2031
$0.38 × 4.9 P/S
$1.87
Worth today
÷ 1.10^5: your 10% a year, taken back out
$1.16
Fair value
The most you can pay and still earn 10% a year
$1.16
Buy below
Fair value minus your 25% margin of safety
$0.87
Every rule is on the methodology page.
Outcome
What your assumptions give, and the path from today's price.
Fair value
$1.16
Expected return
Set a buy price
Future price, 2031
$1.87
Buy below
$0.87
Projection
Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.
Arcellx (ACLX) intrinsic value and fair value
The calculator grows one of Arcellx's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for ACLX; this is analysis, not investment advice.
Frequently asked
What is Arcellx's (ACLX) intrinsic value?+
With Intrinsiqq's starting inputs, Arcellx's fair value is about $1.16 a share, based on its revenue per share. That assumes revenue per share of $0.38 grows about 0.0% a year for 5 years, the stock then trades at 4.9 times revenue, and you want a 10.0% yearly return. Every input can be changed on the page; the result is a model, not a forecast.
What growth does the Arcellx valuation assume?+
Revenue per share grows about 0.0% a year to start, its own recent growth per share (three years for a company not yet profitable, five otherwise). The exit multiple starts at its industry's median.
What is a good margin of safety for Arcellx?+
A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at $0.87. Less predictable businesses deserve a wider cushion, or a higher desired return.
SourceFair value computed from the 10-Q filed 20 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 25 Sept 2026. How this is calculated.
Fiscal year ends Dec.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ACLX
Spot a number that looks wrong? Check it in ACLX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ACLX
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.